| 14.28 Data as of Jun 19 |  -0.22 / -1.52%Today’s Change | 10.15 Today|||52-Week Range 17.15 | +26.93% Year-to-Date |
| A Hidden Reason Nxstage Medical's Future Looks Bright Jun 18 / MotleyFool.com |
| Previous close | 14.50 |
| Today’s open | 14.52 |
| Day’s range | -- - -- |
| Volume | 257,779 |
| Average volume (3 months) | 308,286 |
| Market cap | $866.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +33.33% |
| Earnings growth (this year) | +0.64% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +11.45% |
| P/E ratio | NM |
| Price/Sales | 2.69 |
| Price/Book | 4.35 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXELExelixis Inc | -0.10 | -2.07% |
| BRLIBio-Reference Labora... | -0.10 | -0.35% |
| AMRNAmarin Corporation P... | -0.13 | -1.97% |
| IDIXIdenix Pharmaceutica... | -0.10 | -1.86% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $242.1M |
| Annual profit (last year) | -$15.2M |
| Net profit margin | -6.26% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Jeffrey H. Burbank |
Chief Financial Officer, Treasurer & Senior VP Robert S. Brown, MBA, CPA |
Corporate headquarters Lawrence, Massachusetts |
.
